Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching

DSpace/Manakin Repository

Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching

Citable link to this page

. . . . . .

Title: Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching
Author: Alimzhanov, Marat B.; Coakley, Kristen M.; Alt, Frederick W.; Wang, Jing; Gostissa, Monica; Datta, Abhishek; Murphy, Michael C.; Rajewsky, Klaus; Manis, John P.; Yan, Catherine T.

Note: Order does not necessarily reflect citation order of authors.

Citation: Wang, Jing H., Frederick W. Alt, Monica Gostissa, Abhishek Datta, Michael Murphy, Marat B. Alimzhanov, Kristen M. Coakley, Klaus Rajewsky, John P. Manis, and Catherine T. Yan. 2008. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. The Journal of Experimental Medicine 205(13): 3079-3090.
Full Text & Related Files:
Abstract: Nonhomologous end-joining (NHEJ) repairs DNA double-strand breaks (DSBs) during V(D)J recombination in developing lymphocytes and during immunoglobulin (Ig) heavy chain (IgH) class switch recombination (CSR) in peripheral B lymphocytes. We now show that CD21-cre–mediated deletion of the Xrcc4 NHEJ gene in p53-deficient peripheral B cells leads to recurrent surface Ig-negative B lymphomas (“CXP lymphomas”). Remarkably, CXP lymphomas arise from peripheral B cells that had attempted both receptor editing (secondary V[D]J recombination of Igκ and Igλ light chain genes) and IgH CSR subsequent to Xrcc4 deletion. Correspondingly, CXP tumors frequently harbored a CSR-based reciprocal chromosomal translocation that fused IgH to c-myc, as well as large chromosomal deletions or translocations involving Igκ or Igλ, with the latter fusing Igλ to oncogenes or to IgH. Our findings reveal peripheral B cells that have undergone both editing and CSR and show them to be common progenitors of CXP tumors. Our studies also reveal developmental stage-specific mechanisms of c-myc activation via IgH locus translocations. Thus, Xrcc4/p53-deficient pro–B lymphomas routinely activate c-myc by gene amplification, whereas Xrcc4/p53-deficient peripheral B cell lymphomas routinely ectopically activate a single c-myc copy.
Published Version: doi:10.1084/jem.20082271
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605230/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4853410

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters